Current Opinion in Oncology
This review summarizes the recent data supporting the early use of novel androgen receptor inhibitors in advanced prostate cancer and aims to frame how these drugs may fit within the existing context of docetaxel and abiraterone.
The Cancer Journal
Until recently, men with metastatic prostate cancer were commenced on androgen deprivation therapy at diagnosis, followed by sequential lines of treatment with the development of castration resistance.
American Journal of Clinical Oncology
This article compares the efficacy and safety of systemic therapies used for patients with nonmetastatic castration-resistant prostate cancer (nmCRPC).
Read an excerpt on Prostate Cancer from The Bethesda Review of Clinical Oncology and test your knowledge with Quizzes and Cases
Read the Chapter >
Test your Knowledge >
Read a chapter on Prostate Cancer from Cancer Screening Decisions: A Patient-Based Approach from Ronald Adler, MD.
Download Now >
Download Now >